ALBERT DAVID
|
The Current P/E Ratio of ALBERT DAVID is -268.38.
| Share Price | ₹704.9 | Jul 06,2026 |
| Market Cap | ₹401.8 Cr | |
| Earnings-TTM | ₹-1.5 Cr | TTM-Standalone Results |
| Price/Earnings | -268.38x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ALBERT DAVID
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹401.8 Cr] as on Jul 06,2026
(/) Earnings [ ₹-1.5 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ -268.38x ]
Thus, for ALBERT DAVID , the investors are currently willing to pay -268.38 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALBERT DAVID !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALBERT DAVID over the last five years.
Historical PE (Price/Earnings) ratio chart of ALBERT DAVID
PE Ratio Performance Analysis for ALBERT DAVID
- ALBERT DAVID 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 12.29x.
- ALBERT DAVID 's operated at median p/e ratio of 8.61x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALBERT DAVID 's p/e ratio peaked in Mar2025 at 26.92x.
- ALBERT DAVID 's p/e ratio hit its five-year low in Mar2023 of 8.08x.
How does ALBERT DAVID 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ALBERT DAVID | -1.50 | -268.38 | 401.8 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 39.69 | 459,005.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 70.82 | 181,867.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 76.35 | 163,246.0 |
| CIPLA LTD | 3,869.79 | 30.71 | 118,854.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 27.57 | 114,246.0 |
| MANKIND PHARMA LTD | 1,926.41 | 54.46 | 104,911.0 |
| LUPIN LTD | 5,355.47 | 21.28 | 113,963.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 22.78 | 114,518.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 26.19 | 91,709.5 |
| LAURUS LABS LTD | 889.85 | 92.84 | 82,615.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALBERT DAVID 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -268.38x |
| Max industry PE | 92.84x |
| Median industry PE | 30.71x |
| Average industry PE | 17.67x |
You may also like the below Video Courses